menu search

Intercept pharmaceuticals stock tumbles toward 11-month low after disappointing fda committee vote

Shares of Intercept Pharmaceuticals Inc. ICPT, -1.95% tumbled 15.2% toward an 11-month low in premarket trading Monday, after the biopharmaceutical co...

May 22, 2023, 7:38 am

A perfect storm in pharmacotherapy: the opportunity to invest in nash

NASH, or nonalcoholic steatohepatitis, is a liver inflammatory disease that can progress to fibrosis an...

March 29, 2023, 11:40 pm

Biotech stock surges on mid-stage drug trial success

The shares of 89bio Inc   ( NASDAQ:ETNB) are up 38.2% to trade at $15.11 at last check, after the biotech name revealed its experimental drug pegozaf...

March 22, 2023, 10:49 am

Kotak institutional equities downgrades nalco citing unfavourable risk-reward

The capex for the alumina refinery may also result in nalco seeing negative free cashflow over a simila...

January 12, 2023, 5:44 am

Madrigal (mdgl) soars as resmetirom meets goal in nash study

Madrigal's (MDGL) phase III MAESTRO-NASH study evaluating resmetirom for treating nonalcoholic steatohe...

December 20, 2022, 12:47 pm

Madrigal’s stock rallies about 200% after sharing positive data about its nash treatment candidate

Shares of Madrigal Pharmaceuticals Inc. soared 209.6% in premarket trading on Monday after the company shared positive data from a pivotal Phase 3 cli...

December 19, 2022, 1:07 pm

Why madrigal pharmaceuticals stock is crushing it today

The company reported stellar late-stage clinical trial results for its experimental NASH (nonalcoholic ...

December 19, 2022, 11:50 am

Madrigal pharmaceuticals shares soar on positive trial results for its nash and liver fibrosis drug resmetirom

Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) shares have soared more than 250% after the biopharmaceutical company shared positive topline results from ...

December 19, 2022, 10:41 am

Why is madrigal pharmaceuticals (mdgl) stock up 216% today?

Madrigal Pharmaceuticals (NASDAQ: MDGL ) stock is rocketing higher on Monday after sharing results from its novel therapeutics for no...

December 19, 2022, 9:48 am

Madrigal's stock rallies about 200% after sharing positive data about its nash treatment candidate

Shares of Madrigal Pharmaceuticals Inc. MDGL, +1.43% soared 209.6% in premarket trading on Monday after the company shared positive data from a pivota...

December 19, 2022, 8:07 am

Madrigal pharmaceuticals to announce topline results from the phase 3 maestro-nash study of resmetirom on monday, december 19th

CONSHOHOCKEN, Pa., Dec. 18, 2022 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursui...

December 18, 2022, 9:00 pm

Madrigal pharmaceuticals to announce topline results from the phase 3 maestro-nash study of resmetirom on monday, december 19th

CONSHOHOCKEN, Pa., Dec. 18, 2022 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuin...

December 18, 2022, 4:00 pm

Altimmune appears to have a winner, but will the market believe?

On September 14, shares plummeted 27% on topline results from a Phase 1 study of pemvidutide. Reductions in liver fat appear to be substantially bette...

December 2, 2022, 10:19 am


Search within

Pages Search Results: